We offer a novel tool for antibiotic treatment. Our approach targets a broad spectrum of bacteria but eliminates the risk of evolving resistance by targeting a multitude of pathways.

Our novel gene editing removes the immunogenicity of human Pluripotent Stem Cells upon implantation into human organs. We have chosen Type 1 Diabetes as the initial indication to demonstrate the potential of our platform.

We have developed a smart pessary that features customized design for increased comfort and compliance and sensors to monitor vaginal health.

University of Arizona researchers have developed an affordable precision brace technology for carpal tunnel relief, delivering targeted compression and customized comfort to transform hand health.

Senfina offers in vivo whole life drug discovery services for aging and age-related diseases based on a multi-feature high-throughput imaging platform using C. elegans as a model organism.

Aquaculture is the fastest growing food production sector in the world yet suffers 10% annual losses due to diseases (that’s ~$25 billion lost). Tools for control of these diseases are insufficient or too expensive. Efficacious and inexpensive solutions to address aquaculture disease are an industry priority. Our viral vector platform can be a solution - flexible and customizable to address finfish and crustacean diseases. It can be delivered orally to lower cost and make it more universally applicable to the industry.

UArizona researchers have created an AI powered data-driven tool to forecast a personalized due date window for expectant mothers utilizing data from commonly worn personal devices like smart rings at various periods in gestation.

Our novel peptide design platform helps to overcome the limitations of hyaluronic acid utility in cosmetic and therapeutic applications by forming stabilized gels.